CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

J Bousquet^{1

2

3}, G L Onorato¹, C Bachert⁴, M Barbolini⁵, A Bedbrook¹, L Bjermer⁶, J Correia de Sousa⁷, N H Chavannes⁸, A A Cruz^{9

10}, E De Manuel Keenoy¹¹, P Devillier¹², J Fonseca^{13

14}, S Hun¹⁵, T Kostka¹⁶, P W Hellings¹⁷, M Illario¹⁸, J C Ivancevich¹⁹, D Larenas-Linnemann²⁰, J Millot-Keurinck²¹, D Ryan²², B Samolinski²³, A Sheikh²⁴, A Yorgancioglu^{25

26}, I Agache²⁷, S Arnavielhe²⁸, M Bewick²⁹, I Annesi-Maesano³⁰, J M Anto^{31

32

33

34}, K C Bergmann^{35

36}, C Bindslev-Jensen³⁷, S Bosnic-Anticevich^{38

39}, J Bouchard^{40

41}, D P Caimmi^{42

43}, P Camargos⁴⁴, G W Canonica⁴², V Cardona⁴⁵, A M Carriazo⁴⁶, C Cingi⁴⁷, E Colgan⁴⁸, A Custovic⁴⁹, R Dahl^{9

10}, P Demoly⁴³, G De Vries⁵⁰, W J Fokkens⁵¹, J F Fontaine⁵², B Gemicioğlu⁵³, N Guldemond⁵⁴, Z Gutter⁵⁵, T Haahtela⁵⁶, B Hellqvist-Dahl⁵⁷, E Jares⁵⁸, G Joos⁵⁹, J Just^{60

61}, N Khaltaev⁶², T Keil^{63

64}, L Klimek⁶⁵, M L Kowalski⁶⁶, I Kull⁶⁷, P Kuna⁶⁸, V Kvedariene⁶⁹, D Laune²⁸, R Louis⁷⁰, A Magnan⁷¹, J Malva^{72

73}, E Mathieu-Dupas²⁸, E Melén⁷⁴, E Menditto⁷⁵, M Morais-Almeida⁷⁶, R Mösges⁷⁷, J Mullol⁷⁸, R Murray⁷⁹, H Neffen⁸⁰, R O'Hehir^{81

82}, S Palkonen⁸³, N G Papadopoulos^{84

85}, G Passalacqua⁸⁶, J L Pépin⁸⁷, F Portejoie¹, D Price^{88

89

90}, B Pugin¹⁷, F Raciborski²³, F E R Simons⁹¹, M Sova⁹², O Spranger⁹³, C Stellato⁹⁴, A Todo Bom⁹⁵, P V Tomazic⁹⁶, M Triggiani⁹⁴, A Valero⁹⁷, E Valovirta⁹⁷, O VandenPlas⁹⁸, A Valiulis⁹⁸, M van Eerd⁵⁰, M T Ventura⁹⁹, M Wickman⁷⁴, I Young¹⁰⁰, T Zuberbier^{35

36}, A Zurkuhlen¹⁰¹, A Senn¹⁰²

Affiliations

¹ Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
³ CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
⁴ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
⁵ Regione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing, Bologna, Italy.
⁶ Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden.
⁷ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
⁸ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
⁹ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
¹⁰ GARD Executive Committee, Salvador, Brazil.
¹¹ Kronikgune, International Centre of Excellence in Chronicity Research Barakaldo, Bizkaia Bilbao, Spain.
¹² Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
¹³ Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
¹⁴ Allergy Unit, CUF Porto Instituto and Hospital, Porto, Portugal.
¹⁵ Public Health Agency Northern Ireland, Belfast, UK.
¹⁶ Department of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC), Lodz, Poland.
¹⁷ Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
¹⁸ Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
¹⁹ Allergy and Immunology Department, Santa Isabel, Buenos Aires, Argentina.
²⁰ Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico, Mexico.
²¹ Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR), 34000 Montpellier, France.
²² Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
²³ Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
²⁴ Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
²⁵ Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
²⁶ GARD Executive Committee, Manisa, Turkey.
²⁷ Faculty of Medicine, Transylvania University, Brasov, Romania.
²⁸ Kyomed, Montpellier, France.
²⁹ iQ4U Consultants Ltd, London, UK.
³⁰ EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
³¹ Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
³² IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
³³ CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
³⁴ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
³⁵ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
³⁶ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
³⁷ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
³⁸ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
³⁹ Personalized Medicine Clinic Asthma and Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan Italy.
⁴⁰ Laval's University, Quebec City, Canada.
⁴¹ Hôpital de la Malbaie, Quebec City, Canada.
⁴² CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
⁴³ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
⁴⁴ Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁴⁵ Allergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
⁴⁶ Regional Ministry of Health of Andalusia, Seville, Spain.
⁴⁷ ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
⁴⁸ Department of Health, Social Services and Public Safety, Belfast, Northern Ireland, UK.
⁴⁹ Department of Pediatric, Imperial College London, London, UK.
⁵⁰ Peercode DV, Gerdermalsen, The Netherlands.
⁵¹ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
⁵² Allergist, Reims, France.
⁵³ Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
⁵⁴ Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
⁵⁵ University Hospital Olomouc - National eHealth Centre, Olomouc, Czech Republic.
⁵⁶ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁵⁷ Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
⁵⁸ Libra Foundation, Buenos Aires, Argentina.
⁵⁹ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
⁶⁰ Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
⁶¹ UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Sorbonne Universités, 75013 Paris, France.
⁶² GARD Chairman, Geneva, Switzerland.
⁶³ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁶⁴ Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Würzburg, Germany.
⁶⁵ Center for Rhinology and Allergology, Wiesbaden, Germany.
⁶⁶ Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, and HARC, Lodz, Poland.
⁶⁷ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet Stockholm, Stockholm, Sweden.
⁶⁸ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
⁶⁹ Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
⁷⁰ Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
⁷¹ Service de Pneumologie, UMR INSERM, UMR1087 and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
⁷² Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁷³ Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
⁷⁴ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁷⁵ CIRFF, Federico II University, Naples, Italy.
⁷⁶ Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisbon, Portugal.
⁷⁷ Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
⁷⁸ Clinical and Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain.
⁷⁹ Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth Ireland.
⁸⁰ Argentina Center for Allergy and Immunology, Alassia Children's Hospital, Santa Fe, Santa Fe, Argentina.
⁸¹ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
⁸² Department of Immunology, Monash University, Melbourne, VIC Australia.
⁸³ EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
⁸⁴ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, M13 9WL UK.
⁸⁵ Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou,", University of Athens, Athens, 11527 Greece.
⁸⁶ Allergy and Respiratory Diseases, IRCCS San Martino Hospital, IST-University of Genoa, Genoa, Italy.
⁸⁷ CHU Grenoble, La Tronche, France.
⁸⁸ Observational and Pragmatic Research Institute, Singapore, Singapore.
⁸⁹ Optimum Patient Care, Cambridge, UK.
⁹⁰ Academic Centre of Primary Care, University of Aberdeen, Aberdeen, UK.
⁹¹ Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba Canada.
⁹² University Hospital Olomouc, Olomouc, Czech Republic.
⁹³ Global Allergy and Asthma Platform GAAPP, Altgasse 8-10, 1130 Vienna, Austria.
⁹⁴ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
⁹⁵ Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁹⁶ Department of ENT, Medical University of Graz, Graz, Austria.
⁹⁷ Pneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
⁹⁸ Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
⁹⁹ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁰⁰ Queen's University Belfast, Belfast, Northern Ireland, UK.
¹⁰¹ Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
¹⁰² EC-CNECT-H2, European Commission, Brussels, Belgium.

PMID: 29075437
PMCID: PMC5654064
DOI: 10.1186/s13601-017-0173-8

Review

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

J Bousquet et al. Clin Transl Allergy. 2017.

. 2017 Oct 23:7:37.

doi: 10.1186/s13601-017-0173-8. eCollection 2017.

Authors

Affiliations

¹ Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
³ CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
⁴ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
⁵ Regione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing, Bologna, Italy.
⁶ Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden.
⁷ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
⁸ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
⁹ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
¹⁰ GARD Executive Committee, Salvador, Brazil.
¹¹ Kronikgune, International Centre of Excellence in Chronicity Research Barakaldo, Bizkaia Bilbao, Spain.
¹² Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
¹³ Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
¹⁴ Allergy Unit, CUF Porto Instituto and Hospital, Porto, Portugal.
¹⁵ Public Health Agency Northern Ireland, Belfast, UK.
¹⁶ Department of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC), Lodz, Poland.
¹⁷ Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
¹⁸ Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
¹⁹ Allergy and Immunology Department, Santa Isabel, Buenos Aires, Argentina.
²⁰ Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico, Mexico.
²¹ Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR), 34000 Montpellier, France.
²² Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
²³ Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
²⁴ Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
²⁵ Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
²⁶ GARD Executive Committee, Manisa, Turkey.
²⁷ Faculty of Medicine, Transylvania University, Brasov, Romania.
²⁸ Kyomed, Montpellier, France.
²⁹ iQ4U Consultants Ltd, London, UK.
³⁰ EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
³¹ Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
³² IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
³³ CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
³⁴ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
³⁵ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
³⁶ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
³⁷ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
³⁸ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
³⁹ Personalized Medicine Clinic Asthma and Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan Italy.
⁴⁰ Laval's University, Quebec City, Canada.
⁴¹ Hôpital de la Malbaie, Quebec City, Canada.
⁴² CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
⁴³ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
⁴⁴ Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁴⁵ Allergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
⁴⁶ Regional Ministry of Health of Andalusia, Seville, Spain.
⁴⁷ ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
⁴⁸ Department of Health, Social Services and Public Safety, Belfast, Northern Ireland, UK.
⁴⁹ Department of Pediatric, Imperial College London, London, UK.
⁵⁰ Peercode DV, Gerdermalsen, The Netherlands.
⁵¹ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
⁵² Allergist, Reims, France.
⁵³ Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
⁵⁴ Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
⁵⁵ University Hospital Olomouc - National eHealth Centre, Olomouc, Czech Republic.
⁵⁶ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁵⁷ Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
⁵⁸ Libra Foundation, Buenos Aires, Argentina.
⁵⁹ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
⁶⁰ Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
⁶¹ UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Sorbonne Universités, 75013 Paris, France.
⁶² GARD Chairman, Geneva, Switzerland.
⁶³ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁶⁴ Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Würzburg, Germany.
⁶⁵ Center for Rhinology and Allergology, Wiesbaden, Germany.
⁶⁶ Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, and HARC, Lodz, Poland.
⁶⁷ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet Stockholm, Stockholm, Sweden.
⁶⁸ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
⁶⁹ Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
⁷⁰ Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
⁷¹ Service de Pneumologie, UMR INSERM, UMR1087 and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
⁷² Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁷³ Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
⁷⁴ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁷⁵ CIRFF, Federico II University, Naples, Italy.
⁷⁶ Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisbon, Portugal.
⁷⁷ Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
⁷⁸ Clinical and Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain.
⁷⁹ Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth Ireland.
⁸⁰ Argentina Center for Allergy and Immunology, Alassia Children's Hospital, Santa Fe, Santa Fe, Argentina.
⁸¹ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
⁸² Department of Immunology, Monash University, Melbourne, VIC Australia.
⁸³ EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
⁸⁴ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, M13 9WL UK.
⁸⁵ Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou,", University of Athens, Athens, 11527 Greece.
⁸⁶ Allergy and Respiratory Diseases, IRCCS San Martino Hospital, IST-University of Genoa, Genoa, Italy.
⁸⁷ CHU Grenoble, La Tronche, France.
⁸⁸ Observational and Pragmatic Research Institute, Singapore, Singapore.
⁸⁹ Optimum Patient Care, Cambridge, UK.
⁹⁰ Academic Centre of Primary Care, University of Aberdeen, Aberdeen, UK.
⁹¹ Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba Canada.
⁹² University Hospital Olomouc, Olomouc, Czech Republic.
⁹³ Global Allergy and Asthma Platform GAAPP, Altgasse 8-10, 1130 Vienna, Austria.
⁹⁴ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
⁹⁵ Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁹⁶ Department of ENT, Medical University of Graz, Graz, Austria.
⁹⁷ Pneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
⁹⁸ Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
⁹⁹ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁰⁰ Queen's University Belfast, Belfast, Northern Ireland, UK.
¹⁰¹ Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
¹⁰² EC-CNECT-H2, European Commission, Brussels, Belgium.

PMID: 29075437
PMCID: PMC5654064
DOI: 10.1186/s13601-017-0173-8

Abstract

A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.

Keywords: ARIA; Asthma; CHRODIS; Good Practices; MASK; Rhinitis; Sunfrail.

PubMed Disclaimer

Figures

**Fig. 1**
Care pathways for rhinitis (from Bousquet et al. [2, 3])

See this image and copyright information in PMC

References

1. Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the european geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361–362. doi: 10.1016/j.eurger.2014.09.010. - DOI
1. Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. doi: 10.1183/09031936.00014614. - DOI - PubMed
1. Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. doi: 10.1183/13993003.01856-2015. - DOI - PubMed
1. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223. doi: 10.1111/j.1398-9995.2007.01307.x. - DOI - PubMed
1. Bousquet J, Bourquin C, Augé P, Domy P, Bringer J, Camuzat T, et al. MACVIA-LR reference site of the european innovation partnership on active and healthy ageing. Eur GeriatrMed. 2014;5(6):406–415. doi: 10.1016/j.eurger.2014.07.013. - DOI

Publication types

Actions

Grants and funding

G1000758/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Affiliations

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Authors

Affiliations

Abstract

Figures

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources